Maximum attention on minimal residual disease
GRAIL announces collaborations with three industry giants to evaluate its platform in cancer MRD testing
diagnostics
PacBio, Invitae set sights on whole-genome sequencing
The companies are aiming to develop a new production-scale platform to expand clinical adoption of whole-genome sequencing
Everlywell signs distribution agreement with Ginkgo Bioworks
Everlywell will distribute FDA-authorized rapid antigen testing for organizations and public health agencies
Agreeing on antibiotics
Hoth Therapeutics collaborates with USAMRDC to treat multi-drug resistant bacterial lung infections
In search of HRD harmony
Friends of Cancer Research unites industry, academia and regulatory partners in an effort to realize the potential of homologous recombination deficiency in cancer prognosis
A rapid COVID-19 breath test heads to trial
A human trial for COVID-19 ultra-rapid breath test has begun in Delhi, India…
